Charles Schwab Corporation Short-Term Borrowings decreased by 88.2% to $1.00B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 81.8%, from $5.50B to $1.00B. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.50B | $3.00B | $4.86B | $4.23B | $1.35B | $500.00M | $17.05B | $196.00M | $1.21B | $4.40B | $0.00 | $2.51B | $5.50B | $6.93B | $8.47B | $1.00B |
| QoQ Change | — | -14.3% | +61.8% | -12.8% | -68.1% | -63.0% | >999% | -98.9% | +515.3% | +265.0% | -100.0% | — | +119.5% | +26.0% | +22.3% | -88.2% |
| YoY Change | — | — | — | — | -61.4% | -83.3% | +251.2% | -95.4% | -10.7% | +780.4% | -100.0% | +107.7% | +24.9% | — | +238.2% | -81.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.